March 4, 2025 · Form 4 insider transaction
Brackmann Christoph bought 54,975 shares of NovoCure Limited at $18.19 per share, a transaction worth $1000.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.